Literature DB >> 18502661

Myocardial tissue engineering: the extracellular matrix.

Payam Akhyari1, Hiroyuki Kamiya, Axel Haverich, Matthias Karck, Artur Lichtenberg.   

Abstract

More than a decade after the first reports on successful three-dimensional cardiac cell culture for experimental and potential therapeutic application, the interest and experimental efforts in the field of myocardial tissue engineering continues to grow. The hope that tissue cultures may one day act as graft substitute for malfunctioning myocardium continues to drive current scientific activity. Against this background interest seem to have progressively shifted towards the aim of engineering single tissue components. Accordingly, elements of the extracellular matrix (ECM) have gained increasing attention as potentially crucial mediators in developing and maintaining the characteristics of three-dimensional cardiac cell cultures. The ECM is now no longer regarded as merely a scaffold for developing tissue, a concept that is widely acknowledged in modern tissue engineering. The understanding of the role of precursor and stem cells has highlighted new complicated aspects of cell proliferation and differentiation and ECM proves to play an important role in providing essential signals to influence major intracellular pathways such as proliferation, differentiation and cell metabolism. Furthermore, progress in biochemical engineering has provided the perspective of application of synthetic ECM-linked molecules with bioactive potential. With the advent and continuous refinement of cell removal techniques, a new class of native acellular ECM has emerged with some striking advantages. The presently available ECM materials aim to closely resemble the in vivo microenvironment by acting as an active component of the developing tissue construct. It is therefore not surprising that most of the focus in myocardial tissue engineering has been on cell-matrix interaction, for both naturally derived and synthetic ECM. This article provides a review of established models of myocardial tissue engineering with respect to the employed ECM materials including current frontiers in material development.

Mesh:

Substances:

Year:  2008        PMID: 18502661     DOI: 10.1016/j.ejcts.2008.03.062

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  32 in total

1.  Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells.

Authors:  Stephen Tottey; Mirko Corselli; Eric M Jeffries; Ricardo Londono; Bruno Peault; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2010-09-06       Impact factor: 3.845

2.  A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation.

Authors:  George Kensah; Ina Gruh; Jörg Viering; Henning Schumann; Julia Dahlmann; Heiko Meyer; David Skvorc; Antonia Bär; Payam Akhyari; Alexander Heisterkamp; Axel Haverich; Ulrich Martin
Journal:  Tissue Eng Part C Methods       Date:  2011-01-14       Impact factor: 3.056

3.  Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft.

Authors:  O Schussler; C Coirault; M Louis-Tisserand; W Al-Chare; P Oliviero; C Menard; R Michelot; P Bochet; D R Salomon; J C Chachques; A Carpentier; Y Lecarpentier
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

Review 4.  Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction.

Authors:  Kathy Yuan Ye; Lauren Deems Black
Journal:  J Cardiovasc Transl Res       Date:  2011-08-05       Impact factor: 4.132

5.  Biomimetic microstructure morphology in electrospun fiber mats is critical for maintaining healthy cardiomyocyte phenotype.

Authors:  Rutwik Rath; Jung Bok Lee; Truc-Linh Tran; Sean F Lenihan; Cristi L Galindo; Yan Ru Su; Tarek Absi; Leon M Bellan; Douglas B Sawyer; Hak-Joon Sung
Journal:  Cell Mol Bioeng       Date:  2015-09-08       Impact factor: 2.321

6.  Xenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model.

Authors:  Masashi Kawamura; Shigeru Miyagawa; Satsuki Fukushima; Atsuhiro Saito; Koichi Toda; Takashi Daimon; Tatsuya Shimizu; Teruo Okano; Yoshiki Sawa
Journal:  Tissue Eng Part A       Date:  2015-07-14       Impact factor: 3.845

7.  A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart.

Authors:  Nicholas A Kouris; Jayne M Squirrell; Jangwook P Jung; Carolyn A Pehlke; Timothy Hacker; Kevin W Eliceiri; Brenda M Ogle
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

8.  Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle.

Authors:  J L Ungerleider; T D Johnson; N Rao; K L Christman
Journal:  Methods       Date:  2015-04-02       Impact factor: 3.608

Review 9.  Artificial extracellular matrix for embryonic stem cell cultures: a new frontier of nanobiomaterials.

Authors:  Md Amranul Haque; Masato Nagaoka; Bayar Hexig; Toshihiro Akaike
Journal:  Sci Technol Adv Mater       Date:  2010-02-26       Impact factor: 8.090

Review 10.  Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering.

Authors:  Christina W Cheng; Loran D Solorio; Eben Alsberg
Journal:  Biotechnol Adv       Date:  2014-01-10       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.